Mitochondrial DNA deletions in Kearns-Sayre syndrome;Deleciones del ADN mitocondrial asociadas al síndrome de Kearns-Sayre

Neurologia

Volumn 21, Issue 7, 2006, Pages 357-364

  Carod Artal, F J ^a   Lopez Gallardo E ^b   Solano, A ^b   Dahmani, Y ^b   Herrero, M D ^b   Montoya, Julio ^b  

^a SARAH NETWORK OF REHABILITATION HOSPITALS   (Brazil)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Kearns Sayre syndrome; Mitochondrial disease; mtDNA deletion

Indexed keywords

LACTIC ACID; MITOCHONDRIAL DNA; MUSCLE ENZYME;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; HETEROPLASMY; HUMAN; HUMAN TISSUE; KEARNS SAYRE SYNDROME; MALE; MITOCHONDRIAL DNA DEPLETION; MUSCLE BIOPSY; NEUROLOGIC DISEASE; OPHTHALMOPLEGIA; PERCEPTION DEAFNESS; POLYMERASE CHAIN REACTION; RADIODIAGNOSIS; RETINOPATHY; SYNCOPE;

ADOLESCENT; ADULT; BASE SEQUENCE; BRAIN; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; GENE DELETION; HUMANS; KEARNS-SAYER SYNDROME; KEARNS-SAYRE SYNDROME; MALE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL;

EID: 33749659321     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Longo N. Mitochondrial encephalopathy. Neurol Clin N Am 2003;21:817-31.
2. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophtalmoplegia and complete heart block. Ophtalmology 1958;60:280-9.
3. Berenbaum F, Cote D, Pradat P, Rancurel G. Kearns-Sayre syndrome. Neurology 1990;40:193-4.
4. Bosbacg S, Kornblum C, Schroder R, Wagner M. Executive and visuspatial deficits in patients with chronic progressive external ophtalmoplegia and Kearns-Sayre syndrome. Brain 2003;126: 1231-40.
5. Wilichowski E, Gruters A, Kruse K, Rating D, Beetz R, Korenke GC, et al. Hypoparathyroidism and deafness associated with pleioplasmic large scale rearrangements of the mitochondrial DNA: a clinical and molecular genetic study of four children with Kearns-Sayre syndrome. Pediatr Res 1997;41:193-200.
6. Naranjo IC, Donderis MAC, Beollod VL, Peydro ED. Reversible ischemic neurologic deficit in a patient with the Kearns-Sayre syndrome. Stroke 1988;19:533.
7. Kosinski C, Mull M, Lethen H, Topper R. Evidence for cardioembolic stroke in a case of Kearns-Sayre syndrome. Stroke 1995; 26:1950-2.
8. Provenzale JM, VanLandingham K. Cerebral infarction associated with Kearns-Sayre syndrome-related cardiomyopathy. Neurology 1996;46:826-8.
9. Chabrol B, Paquis V. Cerebral infarction associated with Kearns-Sayre syndrome. Neurology 1997;49:308.
10. Chu BC, Terae S, Takahashi C, Kikuchi Y, Miyasaka K, Abe S, et al. MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review. Neuroradiology 1999;41:759-64.
11. Tanji K, Vu TH, Schon EA, DiMauro S, Bonilla E. Kearns-Sayre syndrome: unusual pattern of expression of subunits of the respiratory chain in the cerebellar system. Ann Neurol 1999;45: 377-83.
12. De Block CE, De Leeuw IH, Maassen JA, Ballaux D, Martin JJ. A novel 7301-bp deletion in mitochondrial DNA in a patient with Kearns-Sayre syndrome, diabetes mellitus, and primary amenorrhoea. Exp Clin Endocrinol Diabet 2004;112:80-3.
13. Uusimaa J, Remes AM, Rantala H, Vainionpää, Herva R, Vuopala K, et al. Childhood encephalopaties and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders. Pediatrics 105;3:598-603.
14. Scaglia F, Towbin JA, Craigen WJ, Belmont JW, Smith EO, Neish SR, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004;114:925-31.
15. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Su ehara M, et al. Cardiac involvement in mitochondrial diseases. Circulation 1995;91:955-61.
16. Katsanos KH, Pappas CJ, Patsouras D, Michalis LK, Kitsios G, Elisaf M, et al. Alarming atrioventricular block and mitral valve prolapse in the Kearns-Sayre syndrome. Int J Cardiol 2002; 83:179-81.
17. Oginosawa Y, Abe H, Nagatomo T, Mizuki T, Nakashima Y. Sustained polymorphic ventricular tachycardia unassociated with QT prolongation or bradycardia in the Kearns-Sayre syndrome. Pacing Clin Electrophysiol 2003;26:1911-2.
18. Zeviani M, Moraes CT, DiMauro S. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1998;51:1525-32.
19. Ashizawa T, Subramony SH. What is Kearns-Sayre syndrome after all? Arch Neurol 2001;58:1053-4.
20. Vázquez-Acevedo M, Vázquez-Memije ME, Mutchinick OM, Morales JJ, García-Ramos G, González-Halphen D. A case of Kearns-Sayre syndrome with the 4,977-bp common deletion associated with a novel 7,704-bp deletion. Neurol Sci 2002;23: 247-50.
21. Marin-García J, Goldenthal MJ, Sarnat HB. Kearns-Sayre syndrome with a novel mitochondrial DNA deletion. J Child Neurol 2000;15:555-8.
22. Tengan CH, Moraes CT. Detection and analysis of mitochondrial DNA deletions by whole genome PCR. Biochem Mol Med 1996; 58:130-4.
23. Schon EA, Rizzuto R, Moraes CT, Nakase H, Zeviani M, DiMauro S. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science 1989;244:346-9.
24. Zhang C, Baumer A, Maxwell RJ, Linnane AW, Nagley P. Multiple mitochondrial DNA deletions in an elderly human individual. FEBS Lett. 1992;297:34-8.
25. Zhang C, Liu VWS, Addessi CL, Sheffield DA, Linnane AW, Nagley P. Differential occurrence of mutations in mitochondrial DNA of human skeletal muscle during aging. Hum Mutat 1998;11:360-71.
26. Rotig A, Goutieres F, Niaudet P, Rustin P, Chretien D, Guest G, et al. Deletion of mitochondrial DNA in patient with chronic tubulointerstitial nephritis. J Pediatr 1995;126:597-601.
27. Mita S, Rizzuto R, Moraes CT, Shanske S, Arnaudo E, Fabrizi GM, et al. Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res 1990;18:561-7.
28. Larson NG, Holme E, Kristiansson B, Oldfors A, Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990;28:131-36.
29. Carod Artal FJ. Enfermedades mitocondriales. En: Jiménez Escrig A, editor. Manual de Neurogenética. Madrid: Díaz de Santos, 2003; p. 255-72.
30. Fromenty B, Carrozzo R, Shanske S, Schon EA. High proportions of mtDNA duplications in patients with Kearns-Sayre syndrome occur in the heart. Am J Med Genet 1997;71:443-52.
31. Akaike M, Kawai H, Yokoi K, Kunishige M, Mine H, Nishida Y, et al. Cardiac dysfunction in patients with chronic progressive external ophthalmoplegia. Clin Cardiol 1997;20:239-43.
32. Muller-Hocker J, Jacob U, Seibel P. The common 4.977 base pair deletion of mitochondrial DNA preferentially accumulates in the cardiac conduction system of patients with Kearns-Sayre syndrome. Mod Pathol 1998;11:295-301.
33. Holt U, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-9.
34. Solano A, Gámez J, Carod FJ, Pineda M, Playan A, López-Gallardo E, et al. Characterisation of repeat and palindrome elements in patients harbouring single deletions of mitochondrial DNA. J Med Genet 2003;40:e86.
35. Barrientos A, Casademont J, Grau JM, Cardellach F, Montoya J, Estivill X, et al. Oftalmoplejia externa progresiva y síndrome de Kearns-Sayre: un estudio clínico y molecular de seis casos. Med Clin (Barc) 1995;105:180-4.
36. Lertrit P, Imsumran A, Karnkirawattana P, Devahasdin V, Sangruchi T, Atchaneeyasakul L et al. A unique 3.5-kb deletion of the mitochondrial genome in Thai patients with Kearns-Sayre syndrome. Hum Genet 1999;105:127-31.
37. De Coo IF, Gussinklo T, Arts PJ, Van Oost BA, Smeets HJ. A PCR test for progressive external ophthalmoplegia and Kearns-Sayre syndrome on DNA from blood samples. J Neurol Sci 1997;149:37-40.
38. Brockington M, Alsanjari N, Sweeney MG, Morgan-Hughes JA, Scaravilli F, Harding AE. Kearns-Sayre syndrome associated with mitochondrial DNA deletion or duplication: a molecular genetic and pathological study. J Neurol Sci 1995;131:78-87.
39. Seneca S, Verhelst H, De Meirleir L, Meire F, Ceuterick-de Groote C, Lissens W, et al. A new mitochondrial point mutation in the transfer RNA(Leu) gene in a patient with a clinical phenotype resembling Kearns-Sayre syndrome. Arch Neurol 2001;58:1053-4.
40. Barthelemy C, Ogier de Baulny H, Diaz J, Cheval MA, Frachon P, Romero N, et al. Late-onset mitochondrial DNA depletion: DNA copy number, multiple deletions, and compensation. Ann Neurol 2001;49:607-17.
41. Puoti G, Carrara F, Sampaolo S, de Caro M, Vincitorio CM, Invernizzi F, et al. Identical large scale rearrangement of a mitochondrial DNA causes Kearns-Sayre syndrome in a mother and her son. J Med Genet 2003;40:858-63.
42. Shanske S, Tang Y, Hirano M, Nishigaki Y, Tanji K, Bonilla E, et al. Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with Pearson syndrome. Am J Hum Genet 2002;71:679-83.